Trial Profile
Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications Viral infections
- Focus Adverse reactions
- 02 Aug 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.